Bryonia isoprenes. II. Cucurbitacin L and bryoamaride fromBryonia melanocarpa
摘要:
Cucurbitacin L and bryoamaride, the predominant components of the bitter principle of Bryonia melanocarpa Nab. (Cucurbitaceae), are isolated from the roots of the plant.
COMPOSITION FOR PROMOTING SECRETION OF EXTRACELLULAR VESICLES
申请人:Nissan Chemical Corporation
公开号:EP3950060A1
公开(公告)日:2022-02-09
This is to provide a composition for promoting secretion of extracellular vesicles.
Provided is a composition for promoting secretion of extracellular vesicles, which comprises a compound having a structure of the formula I (wherein each substituent is as defined in the specification), a racemate thereof or a stereoisomer thereof, or a salt thereof, or a compound having a structure of the formula II (wherein each substituent is as defined in the specification), or a stereoisomer thereof, or a salt thereof, or, cucurbitacin, or a stereoisomer thereof, or a salt thereof.
这是为了提供一种促进细胞外囊泡分泌的组合物。
本发明提供了一种促进细胞外囊泡分泌的组合物,它包括具有式 I 结构的化合物(其中每个取代基均如说明书中所定义)、其外消旋体或其立体异构体或其盐,或具有式 II 结构的化合物(其中每个取代基均如说明书中所定义)、其立体异构体或其盐,或葫芦素、其立体异构体或其盐。
Chemosensory receptor ligand-based therapies
申请人:Anji Pharma (US) LLC
公开号:US10610500B2
公开(公告)日:2020-04-07
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a chemosensory receptor ligand, such as a bitter receptor ligand. Also provided herein are chemosensory receptor ligand compositions, including bitter receptor ligand compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Method and pharmaceutical composition for treating anemia related symptoms. The method and formulation involve the use of one or more cucurbitacin analogs as active ingredients, for example, cucurbitacin D, which are capable of increasing hemoglobin expression, reactivating fetal or adult hemoglobin and inducing γ-globin.